"Now a part of Aspirus Health."

During the past decade, Ascension Saint Mary's Hospital conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 53 clinical trials were completed, i.e. on average, 189.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 32 clinical trials were completed. i.e. 320% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension Saint Mary's Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 57 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "Gynecologic Oncology Group" with 4 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension Saint Mary's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Ascension Saint Mary's Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials), "Clear Cell Renal Cell Carcinoma" (5 trials), "Recurrent Breast Carcinoma" (5 trials) and "Fallopian Tube Transitional Cell Carcinoma" (4 trials). Many other conditions were trialed in "Ascension Saint Mary's Hospital" in a lesser frequency.

Most popular intervention types in "Ascension Saint Mary's Hospital" are "Drug" (76 trials), "Other" (71 trials), "Biological" (43 trials), "Procedure" (19 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Quality-of-Life Assessment" (28 trials), "Paclitaxel" (14 trials), "Bevacizumab" (13 trials) and "Questionnaire Administration" (12 trials). Other intervention names were less common.

The vast majority of trials in "Ascension Saint Mary's Hospital" are 71 trials for "All" genders, 17 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ascension Saint Mary's Hospital". undefined are not yet recruiting, 10 are recruiting, 51 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Ascension Saint Mary's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ascension Saint Mary's Hospital, 1 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".